Borussia Dortmund GmbH & Co. Kommanditgesellschaft auf Aktien (BVB)
Prague Stock Exchange · Czech Republic · prices in CZK · close of 15 Oct 2026
Key indicators
| Last close | CZK 52.55 |
|---|---|
| 52-week range | 35.00 – 77.90 |
| Return, 1 month / 3 months | +0.0% / +0.0% |
| Return, 1 year / 3 years | −32.5% / −41.6% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 79.2% |
| Worst drawdown (1 year) | -55.1% |
| Average daily value traded | 0.00M CZK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Borussia Dortmund is a German professional football club based in Dortmund. It runs a men's football team that competes in the German league and in European club competitions, playing its home matches in a large stadium in the city. The club also develops youth players, sells branded merchandise and operates hospitality and media activities around its matches. Its customers are supporters, sponsors, broadcasters and corporate partners in Germany and abroad.
On this site Borussia Dortmund GmbH & Co. Kommanditgesellschaft auf Aktien appears as a stock on the Prague Stock Exchange (Czech Republic), code BVB, with prices in Czech koruna (CZK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Borussia Dortmund GmbH & Co. Kommanditgesellschaft auf Aktien (BVB) trades on the Prague Stock Exchange in Czech Republic. It last closed at CZK 52.55 on 15 October 2026.
Its price-based Market X-Ray is 17 out of 100 (a weak price profile), ranking 44 of 45 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 32.5% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Prague Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -17.6% | ||
| From 52-week high | -32.5% | ||
| Momentum | 28 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | -32.5% | ||
| 12-month return, skipping the last month | -32.5% | ||
| Stability (higher is calmer) | 13 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 79.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -55.1% | ||
| Liquidity | 2 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M CZK | ||
| Zero-volume days | 100.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.0% |
| 6 months | −32.5% |
| 1 year | −32.5% |
| 3 years | −41.6% |
| 5 years | −57.1% |
Signals
| 50-day / 200-day average | 52.55 / 63.74 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.00 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Prague Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.